FluoRok, a UK company building a novel manufacturing platform for fluorochemicals that bypasses the need for highly hazardous hydrogen fluoride (HF), has closed an oversubscribed $30m (£22.8m) Series…
FluoRok, a UK company building a novel manufacturing platform for fluorochemicals that bypasses the need for highly hazardous hydrogen fluoride (HF), has closed an oversubscribed $30m (£22.8m) Series A financing round. The round was led by Orano Venture Fund/Supernova Invest, alongside investment from Bidra Innovation Ventures, and continued backing from existing investors Oxford Science Enterprises, BGF, GGF, Volta Energy Technologies and the University of Oxford, from which FluoRok was spun out.
This is a source-linked briefing. Read the original report from Industry Europe .